← Leaderboards
Charles Olea
Scripps Research Institute, The
$154,530
Attributed
$154,530
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $53.9K · FY2011–13$100K$75K$50K$25K$0
'11
'12
'13
Funding mix
By agency
NIH$154,530 · 1
By mechanism
F32$154,530 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Hollis T Cline$31,976,615
- Jonathan Thomas Sczepanski$3,899,918
- Anton Maximov$18,276,783
- John J Rossi$761,280
- Donna L Farber$39,655,805
Others in their field
Top investigators on “Assay Development”
- Lawrence Corey · Fred Hutchinson Cancer Center$584,967,044
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$515,753,568
- David Heimbrook · Leidos Biomedical Research, Inc.$438,726,253
- Leonard Freedman · Leidos Biomedical Research, Inc.$296,496,694
- Dennis R. Burton · Scripps Research Institute$271,361,942
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$238,974,575
Research focus
Assay DevelopmentBaseBinding (Molecular Function)BiologicalBiomarkerCancer DetectionCancer RiskCancer TherapyCatalytic RnaCoupledDesignDetectionDevicesDiagnosisDiagnosticDiagnostic Neoplasm StagingEarly DiagnosisEarly TreatmentExplosionFightingFlavin MononucleotideFluorescenceFluorescence Resonance Energy TransferAptamer
Grant awards (3)
Real-time detection of cancer biomarkers using a self-sustained aptazyme$53,942
F32 · FY2013 · CA · contact PI
Real-time detection of cancer biomarkers using a self-sustained aptazyme$52,190
F32 · FY2012 · CA · contact PI
Real-time detection of cancer biomarkers using a self-sustained aptazyme$48,398
F32 · FY2011 · CA · contact PI